Immunotherapy response and resistance in patients with advanced uveal melanoma: a retrospective cohort study - Maurer, Alexander; Clerici, Giulio; Schaab, Jan A.; Cheng, Phil F.; Mihic-Probst, Daniela; Mader, Cäcilia; Messerli, Michael; Huellner, Martin W.; Dummer, Reinhard; Dimitriou, Florentia (Clinical and experimental medicine, 2024)
Keywords: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Antitumor activity; Biopsy; Disease resistance; Drug Resistance, Neoplasm; Female; Hematology; Humans; Immune checkpoint inhibitors; Immunotherapy; Immunotherapy - methods; Internal Medicine; Ipilimumab - therapeutic use; Liver; Liver cancer; Male; Medical prognosis; Medicine; Medicine & Public Health; Melanoma; Melanoma - drug therapy; Melanoma - immunology; Melanoma - pathology; Melanoma - therapy; Metabolic response; Metastases; Middle Aged; Monoclonal antibodies; Nivolumab - therapeutic use; Oncology; Progression-Free Survival; Retrospective Studies; Survival; Treatment Outcome; Uveal Neoplasms - drug therapy; Uveal Neoplasms - immunology; Uveal Neoplasms - mortality; Uveal Neoplasms - pathology; Uveal Neoplasms - therapy; Uveal melanoma; Immune checkpoint inhibitors; Immunotherapy; Tebentafusp